WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 8601 Infant (under 12 months) mortality rate: 532
GDP / capita (US$): 2'2471 Child (under 5 years) mortality rate: 632

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 8'009  7'815  7'627  7'447  7'275  6'186  5'297  3'918 
Births 265  258  249  240  230  189  212  155 
Surviving infants 250  244  235  226  217  176  192  137 
Pop. less than 5 years 1'150  1'096  1'029  981  934  888  955  626 
Pop. less than 15 years 2'874  2'806  2'739  2'698  2'662  2'653  2'311  1'683 
Female 15-49 years 2'113  2'072  2'032  1'984  1'936  1'492  1'175  872 

Number of reported case

(Click for retrospective incidence data for Tajikistan)
Diphtheria 11  11 
Japanese encephalitis
Measles 16  192  6'897 
Mumps 1'518  1'441  1'558  1'200  1'171  428 
Pertussis 56  12  13  935 
Polio* 457 
Rubella 179  124  111 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tajikistan)
Vaccine year result method % card seen                                                
BCG 2011  98  DHS   91.0  97  97  98  83  89  99 
DTP1 2011  97  DHS   91.0  96  98  95  96  92  98 
DTP3 2011  92  DHS   91.0  94  96  93  93  86  96 
HepB_BD          98  98  96  97  85 
HepB3 2011  92  DHS   91.0  94  96  93  93  86 
Hib3 2011  92  DHS   91.0  94  96  93  93  92 
JapEnc         
MCV 2011  95  DHS   91.0  95  98  94  89  86  98 
MCV2          97  96  81  93  87  31 
PCV1         
PCV3         
Pol3 2011  92  DHS   91.0  96  97  95  93  87  98 
Rota1         
Rota_last         
Rubella1          94  89 
TT2plus         
PAB         
VAD1          97  100  98  97  97 
YFV          98 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tajikistan)
BCG 97  97  98  82  89  98 
DTP1 96  98  95  96  92  88 
DTP3 94  96  93  93  86  83 
HepB3 94  96  93  93  86 
Hib3 94  96  93  93  46 
MCV 94  98  94  89  86  88 
PCV3
Pol3 96  97  95  93  87  86 
Rota_last

Number of districts in the country 66  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 97
From 80 to 89% 3
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; 6, 16-17 years; Yes
DT 6 years; Yes
DTwP 16-23 months; Yes
DTwPHibHep 2, 3, 4 months; Yes
HepB birth; Yes
MR 12 months, 6 years; Yes
OPV birth; 2, 3, 4, 12 months; Yes
Td 16, 26, 36 years; Yes
VitaminA 6-11, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2010-2015  2011-2015  2011-2015  2007-2010  2008-2010  2008-2010  NA 
Nº of districts with microplans that include activities to raise immunization coverage number 66  66  65  65  66  65  65 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 66  66  65  65  66  65  65 
Nº districts with DTP3 coverage >=80% number 66  66  65  65  60  65  65 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  91  100  100 
Nº districts with measles (MCV1) coverage >=95% number 59  59  46  63     
% of districts with MCV1 coverage >=95% From 0 to 100% 89  89  71  97     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes           

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 16  18    17    10 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.